3 Stocks That Could Realistically Triple Your Money in 2021

Keith Speights, The Motley Fool
·5 min read
3 Stocks That Could Realistically Triple Your Money in 2021

Altimmune soared nearly 500% last year, primarily due to investors' excitement about its COVID-19 vaccine candidate. Altimmune's AdCOVID is a single-dose intranasal vaccine that holds the potential to be highly effective. The biotech stock has retreated in recent weeks because the U.S. Food and Drug Administration (FDA) placed a clinical hold on Altimmune's application to begin an early-stage clinical study of AdCOVID.